Status:
COMPLETED
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease
Lead Sponsor:
University Health Network, Toronto
Conditions:
Chronic Liver Disease
Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to estimate the usefulness of the QuantiFERON®-TB Gold test for the diagnosis of latent tuberculosis infection in liver transplant candidates by correlating the test result...
Detailed Description
Tuberculosis (TB) is an important cause of morbidity and mortality in organ transplant recipients. Although the tuberculin skin test (TST) is recommended for screening of latent tuberculosis infection...
Eligibility Criteria
Inclusion
- Chronic liver disease on the waiting list or being wait listed for liver transplantation
Exclusion
- Unable to provide informed consent
- Previous history of immediate hypersensitivity to TST
- Previous severe local ulceration with TST
- Suspected active TB
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2007
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00402402
Start Date
October 1 2006
End Date
July 1 2007
Last Update
April 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univcersity Health Network
Toronto, Ontario, Canada, M5G 2N2